Gabriel
Well-Known Member
March. Fauci set out the timeline last Thursday. J&J should have the data it needs to prepare its submission within two weeks (as of last Thursday), after which it will need two more weeks to complete its analysis before it submits. The FDA's analysis of that submission will in turn take around another two weeks, so we're looking at somewhere in March.This keeps getting repeated, but I have seen no evidence to support it.
The data hasn't been supplied to regulators yet - Fauci says next week maybe - so end of Feb is going to be the earliest I would expect.
J&J expects to have 100 million doses available for the US market alone in April. The UK has an order for 30 million, with I think an option to take 22 million more, but I don't know the timescale.
I'm sure I read that J&J has stockpiled in advance, but quite how much and quite where that is heading is harder to determine.